Skip to main content

Research Repository

Advanced Search

Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection

Dhillon, Permesh Singh; Butt, Waleed; Podlasek, Anna; McConachie, Norman; Lenthall, Robert; Nair, Sujit; Malik, Luqman; Bhogal, Pervinder; Makalanda, Hegoda Levansri Dilrukshan; Spooner, Oliver; Krishnan, Kailash; Sprigg, Nikola; Mortimer, Alex; Booth, Thomas Calvert; Lobotesis, Kyriakos; White, Philip; James, Martin A; Bath, Philip; Dineen, Robert A.; England, Timothy J.

Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection Thumbnail


Authors

Permesh Singh Dhillon

Waleed Butt

Anna Podlasek

Norman McConachie

Robert Lenthall

Sujit Nair

Luqman Malik

Pervinder Bhogal

Hegoda Levansri Dilrukshan Makalanda

Oliver Spooner

Kailash Krishnan

Alex Mortimer

Thomas Calvert Booth

Kyriakos Lobotesis

Philip White

Martin A James



Abstract

Background: The effectiveness and safety of endovascular thrombectomy (EVT) in the late window (6-24 hours) for acute ischemic stroke (AIS) patients selected without advanced imaging is undetermined. We aimed to assess clinical outcomes and the relationship with time-to-EVT treatment beyond 6 hours of stroke onset without advanced neuroimaging. Methods: Patients who underwent EVT selected with non-contrast CT/CT angiography (without CT perfusion or MR imaging), between October 2015 and March 2020, were included from a national stroke registry. Functional and safety outcomes were assessed in both early (<6 hours) and late windows with time analyzed as a continuous variable. Results: Among 3278 patients, 2610 (79.6%) and 668 (20.4%) patients were included in the early and late windows, respectively. In the late window, for every hour delay, there was no significant association with shift towards poorer functional outcome (modified Rankin Scale (mRS)) at discharge (adjusted common OR 0.98, 95% CI 0.94 to 1.01, p=0.27) or change in predicted functional independence (mRS ≤2) (24.5% to 23.3% from 6 to 24 hours; aOR 0.99, 95% CI0.94 to 1.04, p=0.85). In contrast, predicted functional independence was time sensitive in the early window: 5.2% reduction per-hour delay (49.4% to 23.5% from 1 to 6 hours, p=0.0001). There were similar rates of symptomatic intracranial hemorrhage (sICH) (3.4% vs 4.6%, p=0.54) and in-hospital mortality (12.9% vs 14.6%, p=0.33) in the early and late windows, respectively, without a significant association with time. Conclusion: In this real-world study, there was minimal change in functional disability, sICH and in-hospital mortality within and across the late window. While confirmatory randomized trials are needed, these findings suggest that EVT remains feasible and safe when performed in AIS patients selected without advanced neuroimaging between 6-24 hours from stroke onset.

Citation

Dhillon, P. S., Butt, W., Podlasek, A., McConachie, N., Lenthall, R., Nair, S., Malik, L., Bhogal, P., Makalanda, H. L. D., Spooner, O., Krishnan, K., Sprigg, N., Mortimer, A., Booth, T. C., Lobotesis, K., White, P., James, M. A., Bath, P., Dineen, R. A., & England, T. J. (2023). Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection. Journal of NeuroInterventional Surgery, 15(4), 336-342. https://doi.org/10.1136/neurintsurg-2021-018564

Journal Article Type Article
Acceptance Date Feb 24, 2022
Online Publication Date Mar 16, 2022
Publication Date 2023-04
Deposit Date Feb 28, 2022
Publicly Available Date Mar 16, 2022
Journal Journal of NeuroInterventional Surgery
Print ISSN 1759-8478
Electronic ISSN 1759-8486
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 15
Issue 4
Pages 336-342
DOI https://doi.org/10.1136/neurintsurg-2021-018564
Keywords Neurology (clinical); General Medicine; Surgery
Public URL https://nottingham-repository.worktribe.com/output/7529504
Publisher URL https://jnis.bmj.com/content/early/2022/03/15/neurintsurg-2021-018564